Autism Speaks Creates Delivering Scientific Innovation for Autism (DELSIA) to accelerate development of products from autism research

DELSIA, an independent not-for-profit affiliate of Autism Speaks, will focus on accelerating the translation of scientific breakthroughs into products that will improve quality of life and health for those affected by autism.

Clara Lajonchere to Present at ARI Conference

Clara Lajonchere, Ph.D., Autism Speaks vice president for clinical programs, will be a featured speaker at the biannual conference of the Autism Research Institute (ARI), October 13-14, in Anaheim, Calif.

NIH Awards $100 Million in Autism Research Grants Funded by CARA

Many ACE Grants Based on Autism Speaks 'Seed' Money

Autism Speaks and SAGEĀ® Labs Expand Collaboration to Develop Rat Models for Translational Autism Research

Unexpected Gene Functions Shown in Initial Studies

Autism Speaks Awards Nearly $2.9 Million to Fund Autism Research

High-Priority Research Will Study the Impact of the Proposed DSM-5 on Autism Diagnosis and much more!

Roche and Seaside Announce Landmark Alliance to Develop Autism Drugs

The deal will pool the resources of Roche, the Swiss pharmaceutical giant, and Seaside Therapeutics, a private 30-employee company based in Cambridge, Mass.

Fever during pregnancy doubles autism risk, study finds

A new study from the UC Davis M.I.N.D. Institute found that women who ran a fever during pregnancy had twice the risk of having a baby with autism. The study offered an easy fix, too: Women who controlled the fever with Tylenol or a similar fever-reducing medication eliminated the risk. PMID 22562209.

Autism Speaks to Play Key Roles at the 2012 International Meeting for Autism Research (IMFAR)

Brings Together More Than 1800 Participants From Around the World to Discuss the Latest Findings on the Causes, Treatments and Diagnoses of Autism

Autism Speaks Selects Prometheus Research to Develop Integrated
Data Management System

Autism Speaks announced a partnership with its Autism Genetic Resource Exchange (AGRE) program and Prometheus Research to build a data management system that will support the integration and centralization of several of Autism Speaks leading data and biospecimen repositories.

Cell Symposia 2011

In November 2011, scientists from around the world gathered in Arlington, Virginia, to discuss how the emerging picture of autism brain pathways can lead to effective treatments for those struggling with disabling symptoms.

Unprecedented Academic-Industry Collaboration Seeks New Drugs and Novel Treatments for Autism

Pharmaceutical Companies, Advocacy Organizations, and Universities Join Forces to Discover New Drugs and Assess Novel Treatment Approaches for Autism

Oct 4: Webinar
Utilizing the AGRE Consortium Data via BioDiscovery Nexus Software to Accelerate Research on Austism Spectrum Disorders

This webinar is geared towards researchers performing copy number and allelic event analysis of the Autism Spectrum Disorders. It is also applicable to anyone interested in a more efficient system to extract meaningful results from genomic aberration data.

Copyright © 2019 Autism Speaks, all rights reserved.